Cellosaurus 21M18 (CVCL_A4BK)
Cell line name | 21M18 |
---|---|
Accession | CVCL_A4BK |
Resource Identification Initiative | To cite this cell line use: 21M18 (RRID:CVCL_A4BK) |
Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8670. Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized demcizumab (OMP-21M18) therapeutic antibody. Monoclonal antibody isotype: Not specified. Monoclonal antibody target: UniProtKB; Q9NR61; Human DLL4. |
Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
Category | Hybridoma |
Publications | PubMed=19664991; DOI=10.1016/j.stem.2009.05.019 Patent=US9376497 |
Cross-references | |
Encyclopedic resources | Wikidata; Q105505888 |
Entry history | |
Entry creation | 12-Jan-2021 |
Last entry update | 02-May-2024 |
Version number | 6 |